By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Ingredients A-Z > Dangerous/banned > Ayahuasca Components

Ayahuasca Components

GMJ
Last updated: 02/06/2026 19:40
By
Prof. Giorgi Pkhakadze
Share
7 Min Read
SHARE

Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD — GMJ Editorial Board

4 min read|883 words

What is Ayahuasca Components?

Ayahuasca components refer to the psychoactive compounds found in ayahuasca, a traditional plant-based brew used ceremonially by indigenous communities in the Amazon basin. The primary active ingredients are N,N-dimethyltryptamine (DMT) and monoamine oxidase inhibitors (MAOIs), particularly harmine, harmaline, and tetrahydroharmine. DMT is typically derived from plants like Psychotria viridis, while MAOIs come from Banisteriopsis caapi vine.

These compounds are classified as controlled substances in most countries, including the United States where DMT is a Schedule I substance under the Controlled Substances Act. Despite legal restrictions, there has been growing scientific interest in understanding their pharmacological properties and potential therapeutic applications.

Health benefits & uses

Mental health applications (Limited evidence): Small-scale clinical studies have suggested potential benefits for treatment-resistant depression and post-traumatic stress disorder. A pilot study published in Psychological Medicine showed rapid antidepressant effects in patients with severe depression.

Submit Your Paper
GMJ_Submit_Banner

Addiction treatment (Limited evidence): Observational studies have reported improvements in substance use disorders following ayahuasca use in ceremonial contexts, though these findings require validation through controlled trials.

Anxiety and trauma (Limited evidence): Some research indicates potential anxiolytic effects and improvements in trauma-related symptoms, but evidence remains preliminary and largely based on survey data and case reports.

It’s crucial to note that all evidence is considered limited due to small sample sizes, lack of long-term follow-up, and the illegal status of these compounds limiting research opportunities.

How it works

DMT acts as a potent agonist at serotonin receptors, particularly the 5-HT2A receptor, which is associated with mood regulation and consciousness. Under normal circumstances, DMT is rapidly broken down by monoamine oxidase enzymes in the digestive system. The MAOIs in ayahuasca inhibit these enzymes, allowing DMT to be orally active and cross the blood-brain barrier.

The psychoactive effects typically begin 30-60 minutes after consumption and can last 4-6 hours. Neuroimaging studies have shown that these compounds can increase neuroplasticity and promote the formation of new neural connections, which may explain their potential therapeutic effects.

Dosage

No recommended dosage exists for ayahuasca components as they are not approved for therapeutic use and remain illegal in most jurisdictions. There is no established RDA (Recommended Daily Allowance) or UL (Upper Limit) for these substances.

In research settings, doses have varied widely depending on the preparation method and plant material potency. Traditional ceremonial doses are typically determined by experienced practitioners based on individual factors and spiritual context.

Critical note: Any use should only be considered under strict medical supervision in legal research contexts or jurisdictions where permitted.

Food sources

Ayahuasca components are not found in common food sources. The primary botanical sources include:

  • Psychotria viridis (chacruna) – contains DMT
  • Banisteriopsis caapi (ayahuasca vine) – contains MAOIs
  • Various other plants used in traditional preparations

These plants are not consumed as food and are specifically prepared for ceremonial or research purposes. They are not available as dietary supplements in most countries.

Safety & side effects

Ayahuasca components carry significant safety risks and can cause serious adverse effects including:

  • Intense nausea and vomiting
  • Cardiovascular effects (increased heart rate and blood pressure)
  • Psychological distress and panic reactions
  • Risk of psychotic episodes in predisposed individuals
  • Potential for triggering latent psychiatric conditions

Long-term safety data is extremely limited. The intense psychological effects can be unpredictable and potentially traumatizing without proper preparation and support.

Interactions

MAOIs in ayahuasca can cause dangerous interactions with numerous medications and substances:

  • Antidepressants: Potentially fatal serotonin syndrome with SSRIs, SNRIs, and MAOIs
  • Stimulants: Dangerous cardiovascular effects with amphetamines, cocaine, or MDMA
  • Tyramine-rich foods: Hypertensive crisis risk
  • Other psychoactive substances: Unpredictable and potentially dangerous interactions

A strict dietary protocol is typically required before and after use to avoid dangerous interactions.

Who should be cautious

Ayahuasca components are contraindicated for most individuals and particularly dangerous for those with:

  • Personal or family history of psychotic disorders
  • Cardiovascular disease
  • Severe mental health conditions
  • Pregnancy or breastfeeding
  • Current use of psychiatric medications
  • History of seizure disorders

Frequently asked questions

Is ayahuasca legal for research purposes?

In most countries, ayahuasca components remain controlled substances. Some jurisdictions have specific exemptions for research or religious use, but these are extremely limited and require special permissions.

How long do the effects last?

Effects typically begin 30-60 minutes after consumption and can last 4-6 hours, with some residual effects persisting longer.

Can ayahuasca components be detected in drug tests?

Yes, DMT and its metabolites can be detected in urine and other biological samples, though detection windows vary depending on the test used.

Are there any approved therapeutic uses?

Currently, there are no FDA-approved therapeutic uses for ayahuasca components. All research remains experimental and investigational.

What should someone do if experiencing adverse effects?

Immediate medical attention should be sought for any serious adverse reactions. Emergency services should be contacted if there are signs of cardiovascular distress or severe psychological reactions.

Classification:

Typical dose: — · Studied up to: —

References

Authoritative profile & live regulatory status: Ayahuasca Components on SupplementIndex →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
How Coffee Brewing Method Affects Cholesterol: The Science Behind Diterpenes and Filters

Coffee's effect on cholesterol depends entirely on brewing method. Unfiltered coffee—French press,…

Muscle rebuilds in three months, but bone takes twice as long—and protein supplements don’t speed it up

Muscle tissue rebuilds completely every three months, while bone takes up to…

U-shaped sleep curve reveals distinct aging patterns: short sleep drives aging, long sleep signals underlying disease

A Nature study of 500,000 UK adults reveals a U-shaped relationship between…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Tejocote Root

By
Prof. Giorgi Pkhakadze
02/06/2026

Aristolochia

By
Prof. Giorgi Pkhakadze
02/06/2026

Nux Vomica / Strychnine

By
Prof. Giorgi Pkhakadze
02/06/2026

SARMs

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up